Soluble Urokinase Plasminogen Activator Receptor (suPAR) and All-Cause and Cardiovascular Mortality in Diverse Hemodialysis Patients

INTRODUCTION: The soluble receptor of urokinase plasminogen activator (suPAR) is an innate immunity/inflammation biomarker predicting cardiovascular (CV) and non-CV events in various conditions, including type 2 diabetic patients on dialysis. However, the relationship between suPAR and clinical outc...

Descripción completa

Detalles Bibliográficos
Autores principales: Torino, Claudia, Pizzini, Patrizia, Cutrupi, Sebastiano, Postorino, Maurizio, Tripepi, Giovanni, Mallamaci, Francesca, Reiser, Jochen, Zoccali, Carmine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6127402/
https://www.ncbi.nlm.nih.gov/pubmed/30197976
http://dx.doi.org/10.1016/j.ekir.2018.05.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6127402/
https://www.ncbi.nlm.nih.gov/pubmed/30197976
http://dx.doi.org/10.1016/j.ekir.2018.05.004

Ejemplares similares